Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study
- PMID: 36658248
- DOI: 10.1245/s10434-022-13065-z
Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study
Abstract
Background: Application of patient-reported outcomes (PROs) in surgical oncology has been limited because of patient heterogeneity. We analyzed symptom trajectories and their associations with recovery outcomes after lung cancer surgery, aiming to profile the heterogeneity of patients' experiences and to identify patients needing extensive care.
Methods: Symptoms were assessed with the MDASI-LC before surgery, daily after surgery in hospital and weekly within 1 month after discharge. Patients were clustered based on symptoms from post-operative day 1 (POD1) to POD5, using the latent-class-trajectory-model. Functional recovery was compared across the trajectories. Logistic regression was used to explore risk factors for trajectories of more severe symptoms.
Results: Based on the five most severe post-surgery symptoms (pain, fatigue, coughing, shortness of breath, and disturbed sleep), we identified three distinct symptom trajectories among 424 patients [mild, N = 225 (53.07%); severe-to-mild, N = 86 (20.28%); severe, N = 104 (24.53%)]. At discharge, more 'severe' patients (73.96%) did not achieve a functional recovery compared with those in mild (32.54%, P < 0.0001) or severe-to-mild (56.96%, P = 0.0274) groups. Factors of significant symptom increase on POD1 were younger-than-55 (OR = 1.94 [95% CI 1.30-2.93], P = 0.001), undergoing open or multi-port video-assisted thoracoscopic surgery (OR = 1.59 [95% CI 1.05-2.41], P = 0.03), and using two chest tubes (OR = 1.72 [95% CI 1.12-2.65], P = 0.01). For patients experiencing dramatic symptom increase on POD1, older age (OR = 2.51 [95% CI 1.40-4.59], P = 0.002) was associated with 'severe' trajectory.
Conclusions: This study demonstrated that PRO measures were capable of profiling heterogeneous symptom trajectories after lung cancer surgery. Those in-hospital trajectories were able to differentiate patients' responses to treatments and signal the needs for extensive post-discharge care.
© 2023. Society of Surgical Oncology.
Similar articles
-
A score prediction model for predicting the heterogeneity symptom trajectories among lung cancer patients during perioperative period: a longitudinal observational study.Ann Med. 2025 Dec;57(1):2479588. doi: 10.1080/07853890.2025.2479588. Epub 2025 Mar 20. Ann Med. 2025. PMID: 40114445 Free PMC article.
-
Symptom severity trajectories and distresses in patients undergoing video-assisted thoracoscopic lung resection from surgery to the first post-discharge clinic visit.PLoS One. 2023 Feb 22;18(2):e0281998. doi: 10.1371/journal.pone.0281998. eCollection 2023. PLoS One. 2023. PMID: 36812255 Free PMC article.
-
Longitudinal patterns of patient-reported sleep disturbances after surgery for lung cancer.Sleep Breath. 2024 Mar;28(1):441-448. doi: 10.1007/s11325-023-02877-2. Epub 2023 Jul 11. Sleep Breath. 2024. PMID: 37434013
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
-
Monitoring Patient-Reported Outcomes in Self-management of Postsurgical Symptoms in Oncology: A Scoping Review.Cancer Nurs. 2025 Jan-Feb 01;48(1):31-44. doi: 10.1097/NCC.0000000000001250. Epub 2024 Jan 30. Cancer Nurs. 2025. PMID: 37232525
Cited by
-
Factors associated with postoperative discharge readiness and continuing care needs in patients with lung cancer undergoing fast-track surgery: A prospective cohort study.Medicine (Baltimore). 2024 Sep 13;103(37):e39314. doi: 10.1097/MD.0000000000039314. Medicine (Baltimore). 2024. PMID: 39287285 Free PMC article.
-
Efficacy of a smartphone application assisting home-based rehabilitation and symptom management for patients with lung cancer undergoing video-assisted thoracoscopic lobectomy: a prospective, single-blinded, randomised control trial (POPPER study).Int J Surg. 2025 Jan 1;111(1):597-608. doi: 10.1097/JS9.0000000000001845. Int J Surg. 2025. PMID: 38905505 Free PMC article. Clinical Trial.
-
Predictive relationship in perioperative symptoms and step count for lung cancer patients.Support Care Cancer. 2025 Jun 7;33(7):554. doi: 10.1007/s00520-025-09542-2. Support Care Cancer. 2025. PMID: 40481856
-
A study demonstrating users' preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer.Front Oncol. 2024 Apr 10;14:1328871. doi: 10.3389/fonc.2024.1328871. eCollection 2024. Front Oncol. 2024. PMID: 38660130 Free PMC article.
-
Postoperative Symptom Cluster in NSCLC Patients and Its Relationship with Social Support and Self-Efficacy: A Cross-Sectional Study.Risk Manag Healthc Policy. 2025 Apr 17;18:1347-1354. doi: 10.2147/RMHP.S518188. eCollection 2025. Risk Manag Healthc Policy. 2025. PMID: 40260176 Free PMC article.
References
-
- Kluetz PG, Kanapuru B, Lemery S, et al. Informing the tolerability of cancer treatments using patient-reported outcome measures: Summary of an FDA and critical path institute workshop. Value Health. 2018;21(6):742–7. https://doi.org/10.1016/j.jval.2017.09.009 . - DOI - PubMed
-
- Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension. JAMA. 2018;319(5):483–94. https://doi.org/10.1001/jama.2017.21903 . - DOI - PubMed
-
- Janelsins MC, Mohamed M, Peppone LJ, et al. Longitudinal changes in cognitive function in a nationwide cohort study of patients with lymphoma treated with chemotherapy. J Natl Cancer Inst. 2021. https://doi.org/10.1093/jnci/djab133 . - DOI - PubMed - PMC
-
- Schoenbeck KL, Atallah E, Lin L, et al. Patient-reported functional outcomes in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors. J Natl Cancer Inst. 2021. https://doi.org/10.1093/jnci/djab184 . - DOI - PMC
-
- Gonzalez BD, Eisel SL, Bowles KE, et al. Meta-analysis of quality of life in cancer patients treated with immune checkpoint inhibitors. J Natl Cancer Inst. 2021. https://doi.org/10.1093/jnci/djab171 . - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous